(CNNE) Cannae Holdings - Overview

Sector: Consumer Cyclical | Industry: Restaurants | Exchange: NYSE (USA) | Market Cap: 555m USD | Total Return: -36.4% in 12m

Stock Restaurants, Healthcare, Finance
Total Rating 8
Risk 26
Buy Signal -0.20
Restaurants -1.2
Multi-Sector Holdings +16.6
Market Cap: 555m
Avg Trading Vol: 8.35M USD
ATR: 4.38%
Peers RS (IBD): 9.8
Risk 5d forecast
Volatility34.5%
Rel. Tail Risk-2.39%
Reward TTM
Sharpe Ratio-1.19
Alpha-51.54
Character TTM
Beta0.774
Beta Downside1.175
Drawdowns 3y
Max DD49.96%
CAGR/Max DD-0.30
EPS (Earnings per Share) EPS (Earnings per Share) of CNNE over the last years for every Quarter: "2021-03": -2.55, "2021-06": 1.94, "2021-09": -1.36, "2021-12": -1.24, "2022-03": -2.88, "2022-06": -3.15, "2022-09": 0.69, "2022-12": 0.35, "2023-03": -0.05, "2023-06": -1.16, "2023-09": -2.18, "2023-12": -0.83, "2024-03": -1.27, "2024-06": -2.49, "2024-09": -0.22, "2024-12": -0.74, "2025-03": -1.81, "2025-06": -3.75, "2025-09": -1.06, "2025-12": -1.93,
EPS CAGR: 19.63%
EPS Trend: -24.8%
Last SUE: -1.40
Qual. Beats: 0
Revenue Revenue of CNNE over the last years for every Quarter: 2021-03: 171.9, 2021-06: 202.4, 2021-09: 186, 2021-12: 181.9, 2022-03: 167.4, 2022-06: 174.5, 2022-09: 164.5, 2022-12: 155.7, 2023-03: 154.3, 2023-06: 152.8, 2023-09: 143.6, 2023-12: 119.3, 2024-03: 110.7, 2024-06: 118, 2024-09: 113.9, 2024-12: 109.9, 2025-03: 103.2, 2025-06: 110.2, 2025-09: 106.9, 2025-12: 103.3,
Rev. CAGR: -12.08%
Rev. Trend: -94.8%
Last SUE: 0.06
Qual. Beats: 0
Description: CNNE Cannae Holdings March 05, 2026

Cannae Holdings, Inc. (CNNE) is a US-based principal investment firm founded in 2014. It operates within the Multi-Sector Holdings GICS Sub-Industry, indicating a diversified investment approach.

CNNE invests across various sectors, including restaurants, technology-enabled healthcare services, and financial services. The firm employs both minority and majority stake investment strategies. Principal investment firms typically acquire equity in companies with the aim of generating returns through their growth or eventual sale.

For a deeper dive into their portfolio and financial performance, consider exploring ValueRay.

Headlines to Watch Out For
  • Portfolio company performance dictates investment returns
  • Interest rate fluctuations impact financing costs
  • Regulatory changes in healthcare and financial services pose risks
  • Economic downturns reduce consumer spending and investment opportunities
Piotroski VR‑10 (Strict, 0-10) 1.5
Net Income: -513.2m TTM > 0 and > 6% of Revenue
FCF/TA: -0.02 > 0.02 and ΔFCF/TA 2.94 > 1.0
NWC/Revenue: 32.72% < 20% (prev 11.14%; Δ 21.58% < -1%)
CFO/TA -0.01 > 3% & CFO -10.5m > Net Income -513.2m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 2.07 > 1.5 & < 3
Outstanding Shares: last quarter (48.2m) vs 12m ago -22.51% < -2%
Gross Margin: 0.05% > 18% (prev 0.01%; Δ 4.08% > 0.5%)
Asset Turnover: 23.87% > 50% (prev 20.30%; Δ 3.57% > 0%)
Interest Coverage Ratio: -25.59 > 6 (EBITDA TTM -182.2m / Interest Expense TTM 11.9m)
Altman Z'' -0.31
A: 0.10 (Total Current Assets 268.3m - Total Current Liabilities 129.7m) / Total Assets 1.32b
B: 0.02 (Retained Earnings 23.3m / Total Assets 1.32b)
C: -0.17 (EBIT TTM -304.5m / Avg Total Assets 1.77b)
D: 0.09 (Book Value of Equity 29.8m / Total Liabilities 329.8m)
Altman-Z'' Score: -0.31 = B
Beneish M 1.00
DSRI: 1.81 (Receivables 60.6m/35.7m, Revenue 423.6m/452.5m)
GMI: 13.57 (GM 0.05% / 0.64%)
AQI: 0.82 (AQ_t 0.67 / AQ_t-1 0.82)
SGI: 0.94 (Revenue 423.6m / 452.5m)
TATA: -0.38 (NI -513.2m - CFO -10.5m) / TA 1.32b)
Beneish M-Score: 8.49 (Cap -4..+1) = D
What is the price of CNNE shares? As of April 02, 2026, the stock is trading at USD 11.37 with a total of 516,584 shares traded.
Over the past week, the price has changed by +0.70%, over one month by -4.54%, over three months by -26.33% and over the past year by -36.43%.
Is CNNE a buy, sell or hold? Cannae Holdings has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy CNNE.
  • StrongBuy: 1
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the CNNE price?
ISSUER TARGET UP/DOWN
Wallstreet Target Price 19 67.1%
Analysts Target Price 19 67.1%
CNNE Fundamental Data Overview March 30, 2026
P/E Forward = 74.0741
P/S = 1.3108
P/B = 0.4905
Revenue TTM = 423.6m USD
EBIT TTM = -304.5m USD
EBITDA TTM = -182.2m USD
Long Term Debt = 64.5m USD (from longTermDebt, last quarter)
Short Term Debt = 21.7m USD (from shortTermDebt, last quarter)
Debt = 331.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 149.8m USD (from netDebt column, last quarter)
Enterprise Value = 705.0m USD (555.2m + Debt 331.8m - CCE 182.0m)
Interest Coverage Ratio = -25.59 (Ebit TTM -304.5m / Interest Expense TTM 11.9m)
EV/FCF = -33.73x (Enterprise Value 705.0m / FCF TTM -20.9m)
FCF Yield = -2.96% (FCF TTM -20.9m / Enterprise Value 705.0m)
FCF Margin = -4.93% (FCF TTM -20.9m / Revenue TTM 423.6m)
Net Margin = -121.2% (Net Income TTM -513.2m / Revenue TTM 423.6m)
Gross Margin = 0.05% ((Revenue TTM 423.6m - Cost of Revenue TTM 423.4m) / Revenue TTM)
Gross Margin QoQ = 12.39% (prev 5.80%)
Tobins Q-Ratio = 0.53 (Enterprise Value 705.0m / Total Assets 1.32b)
Interest Expense / Debt = 0.45% (Interest Expense 1.50m / Debt 331.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = -240.6m (EBIT -304.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.07 (Total Current Assets 268.3m / Total Current Liabilities 129.7m)
Debt / Equity = 0.32 (Debt 331.8m / totalStockholderEquity, last quarter 1.02b)
 Debt / EBITDA = -0.82 (negative EBITDA) (Net Debt 149.8m / EBITDA -182.2m)
 Debt / FCF = -7.17 (negative FCF - burning cash) (Net Debt 149.8m / FCF TTM -20.9m)
 Total Stockholder Equity = 1.33b (last 4 quarters mean from totalStockholderEquity)
RoA = -28.92% (Net Income -513.2m / Total Assets 1.32b)
RoE = -38.48% (Net Income TTM -513.2m / Total Stockholder Equity 1.33b)
RoCE = -21.78% (EBIT -304.5m / Capital Employed (Equity 1.33b + L.T.Debt 64.5m))
 RoIC = -16.55% (negative operating profit) (NOPAT -240.6m / Invested Capital 1.45b)
 WACC = 5.59% (E(555.2m)/V(887.0m) * Re(8.71%) + D(331.8m)/V(887.0m) * Rd(0.45%) * (1-Tc(0.21)))
Discount Rate = 8.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -17.08%
 [DCF] Fair Price = unknown (Cash Flow -20.9m)
 EPS Correlation: -24.75 | EPS CAGR: 19.63% | SUE: -1.40 | # QB: 0
Revenue Correlation: -94.79 | Revenue CAGR: -12.08% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.44 | Chg7d=+0.030 | Chg30d=+0.030 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=-1.89 | Chg7d=-0.035 | Chg30d=-0.035 | Revisions Net=+0 | Growth EPS=+74.3% | Growth Revenue=-6.4%
EPS next Year (2027-12-31): EPS=-1.70 | Chg7d=-0.045 | Chg30d=-0.045 | Revisions Net=+1 | Growth EPS=+10.3% | Growth Revenue=-0.0%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
Additional Sources for CNNE Stock Fund Manager Positions: Dataroma · Stockcircle